Telix Pharmaceuticals Limited (TLX)
Nasdaq: TLX · Pharmaceutical Preparations · North Melbourne, AU · filing with the SEC since 2024
Who owns Telix Pharmaceuticals Limited
As filed with the SECHolders of 5% or more
2
Behrenbruch Christian holds 6.97% of Ordinary Shares, as its SCHEDULE 13G filed Feb 14, 2025 says.
Directors and officers
10
report now, of 10 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Behrenbruch Christian
SCHEDULE 13G · filed Feb 14, 2025 · Ordinary Shares
Kluge Andreas
SCHEDULE 13G · filed Feb 14, 2025 · Ordinary Shares
What TLX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Atonco SAS
An investee · associate · invested in, named in the 20-F filed Feb 20, 2026
IRMA Surgical
An investee · associate · invested in, named in the 20-F filed Feb 20, 2026
Mauna Kea Technologies
An investee · associate · invested in, named in the 20-F filed Feb 20, 2026
ARTMS Inc
A company bought · acquisition · owns, named in the 20-F filed Feb 20, 2026
Dedicaid GmbH
A company bought · acquisition · owns, named in the 20-F filed Feb 20, 2026
ImaginAb Inc
A company bought · acquisition · owns, named in the 20-F filed Feb 20, 2026
ISO Therapeutics Group, LLC
A company bought · acquisition · owns, named in the 20-F filed Feb 20, 2026
Lightpoint Medical
A company bought · acquisition · owns, named in the 20-F filed Feb 20, 2026
32 subsidiaries in 13 countries, from the list filed with the 20-F filed Feb 20, 2026.
Insider tradesForm 4
0sales
3purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$1.0Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 10 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Behrenbruch Christian | MD & Group CEO | 0 | $0 | 0 | 2 | $1.0M |
| Smith Darren Charlton | Group Chief Financial Officer | 0 | $0 | 0 | 1 | $0 |